[1]
Rios Velazquez, E. et al. 2010. Prediction of residual metabolic activity after treatment in NSCLC patients. Acta Oncologica. 49, 7 (Oct. 2010), 1033–1039. DOI:https://doi.org/10.3109/0284186X.2010.498441.